67 related articles for article (PubMed ID: 2693771)
1. [Clinical significance of the estimations of complement and immune complexes].
Yoshida H; Watanabe K
Rinsho Byori; 1989 Dec; 37(12):1317-23. PubMed ID: 2693771
[TBL] [Abstract][Full Text] [Related]
2. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
Greisman SG; Redecha PB; Kimberly RP; Christian CL
J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
[TBL] [Abstract][Full Text] [Related]
3. [Current situation and problems in the estimation of circulating immune complexes].
Yoshida H
Rinsho Byori; 1992 Jan; 40(1):28-33. PubMed ID: 1545522
[TBL] [Abstract][Full Text] [Related]
4. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
[TBL] [Abstract][Full Text] [Related]
5. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of circulating immune complex assay in patients with systemic lupus erythematosus.
Phi NC; Chien DK; Chinh DV; Péter G
Acta Med Hung; 1989; 46(2-3):109-20. PubMed ID: 2812955
[TBL] [Abstract][Full Text] [Related]
7. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
8. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
9. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
10. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
11. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
12. Identification of components of IC purified from human sera. I. Immune complexes purified from sera of patients with SLE.
Maire MA; Barnet M; Carpentier N; Miescher PA; Lambert PH
Clin Exp Immunol; 1983 Feb; 51(2):215-24. PubMed ID: 6839539
[TBL] [Abstract][Full Text] [Related]
13. [Detection of circulating immune complexes in systemic lupus erythematosus by the method of conglutinin and monoclonal rheumatoid factor].
de Oliveira RM; Marchiori PE; Viana Vdos S; Bueno C; dos Reis M; Quevedo ME; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):6-9. PubMed ID: 4059787
[No Abstract] [Full Text] [Related]
14. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
Baatrup G; Petersen I; Jensenius JC; Svehag SE
Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
[TBL] [Abstract][Full Text] [Related]
15. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
16. Immune complex-like activity associated with abnormal serum lipoproteins in systemic erythematosus.
Smith GW; Hannan SF; Scott PJ; Simpson IJ
Clin Exp Immunol; 1982 Apr; 48(1):8-16. PubMed ID: 6979451
[TBL] [Abstract][Full Text] [Related]
17. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
[TBL] [Abstract][Full Text] [Related]
19. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
Meryhew NL; Kimberly RP; Messner RP; Runquist OA
J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes and platelet IgG in various diseases.
Puram V; Giuliani D; Morse BS
Clin Exp Immunol; 1984 Dec; 58(3):672-6. PubMed ID: 6509798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
